Cancer Biomarkers Market Segmentation:
Cancer Type Segment Analysis
The global cancer biomarkers market is segmented and analyzed for demand and supply by cancer type into breast, lung, prostate, colorectal, stomach, and other Cancers. Out of these segments, the breast cancer segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising prevalence of breast cancer on account of unhealthy lifestyles, genetic inheritance, the rising female geriatric population, and exposure to hazardous radiation. As per the World Health Organization, in 2020, about 2.3 billion women are diagnosed with breast cancer, and 685,000 people died across the world.
Profiling Technology Segment Analysis
The global cancer biomarkers market is also segmented and analyzed for demand and supply by profiling technology into omics technologies, imaging technologies, and immunoassays. Amongst these three segments, the omics technologies segment is expected to garner a significant share. The growth of the segment can be attributed to the high efficiency of omics technologies in the diagnosis of cancer, along with the increasing development of profiling techniques for cancer biomarkers, that is anticipated to boost the market’s growth during the forecast period.
Our in-depth analysis of the global cancer biomarkers includes the following segments:
|
By profiling Technology |
|
|
By Biomolecule |
|
|
By Cancer Type |
|
|
By Application |
|
